MedTrace Logo

Contribution of SuPAR for Patients in a Situation of Uncertainty Downstream of Emergencies

NCT05214534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 202

Last updated 2023-03-13

No results posted yet for this study

Summary

In this study, the investigators will investigate the relationship between the blood level of SuPAR at admission to the emergency department of the Clermont-Ferrand University Hospital, and the outcome of patients after their hospitalization in a short stay unit.

Conditions

  • Emergencies
  • Disease
  • In-hospital Observation

Interventions

OTHER

blood supar measurement

The supar values will be measured afterwards on the tube bottoms of the patients included in the study from their usual collection

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Farès Moustafa · University Hospital, Clermont-Ferrand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2022-04-18
Completion
2022-04-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05214534 on ClinicalTrials.gov